Work

Anti-EGFR resistant clones decay exponentially after progression: Implications for anti-EGFR rechallenge.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.3511

Authors: Christine Megerdichian Parseghian, Jonathan M. Loree, Van Karlyle Morris, Allan Andresson Lima Pereira, Eduardo Vilar Sanchez, Bryan K. Kee, Kanwal Pratap Singh Raghav, A. Dasari, Ji Wu, Victoria M. Raymond, Kimberly Banks, AmirAli Talasaz, Richard B. Lanman, Michael J. Overman, Scott Kopetz

Institutions: The University of Texas MD Anderson Cancer Center, BC Cancer Agency, Instituto do Câncer do Estado de São Paulo, Guardant (United States)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891464997

Cites:

Cited by: 35

Related to: 10